Form 8-K Harmony Biosciences Hold For: Feb 22

Go back to Form 8-K Harmony Biosciences Hold For: Feb 22

Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $34 at Raymond James

February 22, 2024 12:00 PM EST

Raymond James analyst Danielle Brill raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $34.00 (from $27.00) while maintaining a Outperform rating.

The analyst comments "Last month, HRMY preannounced 4Q Wakix sales and provided preliminary FY24 guidance that came in-line w/... More